ConductScience.org, home

Paper40686644

Peptide-based therapeutic and delivery strategies for inflammatory bowel disease: challenges and future directions.

Ge C and 3 others. RSC Adv, 2025. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Peptide-based therapeutic and delivery strategies for inflammatory bowel disease: challenges and future directions. Papers, record 40686644. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40686644

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Peptide-based therapeutic and delivery strategies for inflammatory bowel disease: challenges and future directions.
PubMed
Journal
RSC Adv
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
2.41, provisional
iCite
Revised in PubMed
2025-07-23
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ge CChengmei
2Wang ZZhen
3Wang YYu
4Wei MMeihaohttps://orcid.org/0009-0007-3585-9869

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References155

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139746581Dihydromyricetin/montmorillonite intercalation compounds ameliorates DSS-induced colitis: Role of intestinal epithelial barrier, NLRP3 inflammasome pathway and gut microbiota.Int J Pharm2025https://conductscience.org/library/papers/39746581PubMed
238638365Development of Ac2-26 Mesoporous Microparticle System as a Potential Therapeutic Agent for Inflammatory Bowel Diseases.Int J Nanomedicine2024https://conductscience.org/library/papers/38638365PubMed
325371141Antimicrobial peptides: therapeutic potentials.Expert Rev Anti Infect Ther2014https://conductscience.org/library/papers/25371141PubMed
432768972Site-specific targeted drug delivery systems for the treatment of inflammatory bowel disease.Biomed Pharmacother2020https://conductscience.org/library/papers/32768972PubMed
534713621Polydopamine Nanoparticle-Mediated Dopaminergic Immunoregulation in Colitis.Adv Sci (Weinh)2022https://conductscience.org/library/papers/34713621PubMed
632714090Anti-Inflammatory Effect of a Peptide Derived from the Synbiotics, Fermented Cudrania tricuspidata with Lactobacillus gasseri, on Inflammatory Bowel Disease.Mediators Inflamm2020https://conductscience.org/library/papers/32714090PubMed
739587209Orally delivered biodegradable targeted inflammation resolving pectin-coated nanoparticles induce anastomotic healing post intestinal surgery.Sci Rep2024https://conductscience.org/library/papers/39587209PubMed
833803138Antioxidant Therapy in Inflammatory Bowel Diseases.Antioxidants (Basel)2021https://conductscience.org/library/papers/33803138PubMed
939569007Sturgeon-derived peptide LLLE alleviates colitis via regulating gut microbiota and its metabolites.Curr Res Food Sci2024https://conductscience.org/library/papers/39569007PubMed
1034399466Recent developments on production, purification and biological activity of marine peptides.Food Res Int2021https://conductscience.org/library/papers/34399466PubMed
1135780549Orally administered covalently-assembled antioxidative peptide nanoparticles for inflammatory bowel disease therapy.J Colloid Interface Sci2022https://conductscience.org/library/papers/35780549PubMed
1231157495Efficient Phage Display with Multiple Distinct Non-Canonical Amino Acids Using Orthogonal Ribosome-Mediated Genetic Code Expansion.Angew Chem Int Ed Engl2019https://conductscience.org/library/papers/31157495PubMed
1332097742Chitosan-based hydrogel beads: Preparations, modifications and applications in food and agriculture sectors - A review.Int J Biol Macromol2020https://conductscience.org/library/papers/32097742PubMed
1439321686Targeted V-type peptide-decorated nanoparticles prevent colitis by inhibiting endosomal TLR signaling and modulating intestinal macrophage polarization.Biomaterials2025https://conductscience.org/library/papers/39321686PubMed
1537859689A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatment.Bioact Mater2024https://conductscience.org/library/papers/37859689PubMed
1639554349Structure and regulatory mechanisms of food-derived peptides in inflammatory bowel disease: A review.Food Sci Nutr2024https://conductscience.org/library/papers/39554349PubMed
1735415304Sprayable nanomicelle hydrogels and inflammatory bowel disease patient cell chips for development of intestinal lesion-specific therapy.Bioact Mater2022https://conductscience.org/library/papers/35415304PubMed
1823428883Approaches for enhancing oral bioavailability of peptides and proteins.Int J Pharm2013https://conductscience.org/library/papers/23428883PubMed
1918602004Peptide-mediated interactions in biological systems: new discoveries and applications.Curr Opin Biotechnol2008https://conductscience.org/library/papers/18602004PubMed
2034887639Antimicrobial peptides and the gut microbiome in inflammatory bowel disease.World J Gastroenterol2021https://conductscience.org/library/papers/34887639PubMed

See all 155 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42941186Inflammatory Bowel Disease: From Multifactorial and Metabolic Pathogenesis to Systemic Disease and Precision Medicine.Metabolites2026https://conductscience.org/library/papers/42941186PubMed
42898959Targeting pathogenic immune cells in rheumatoid arthritis: emerging immunotherapeutic frontiers.Front Immunol2026https://conductscience.org/library/papers/42898959PubMed
42796959Adzuki Bean Peptide Prevents DSS-Induced Colitis by Modulating the Gut Microbiota.Nutrients2026https://conductscience.org/library/papers/42796959PubMed
42388373Oral hydrogel systems in lower gastrointestinal disorders: From disease-based therapy to microbiota-guided design.Mater Today Bio2026https://conductscience.org/library/papers/42388373PubMed
42196602Mechanistic Insights into Dihydromyricetin: Redox Modulation and Kinase-Mediated Control of Disease Pathogenesis.Int J Mol Sci2026https://conductscience.org/library/papers/42196602PubMed
42126606Cytokine and chemokine dysregulation by microbial biofilm components: mechanisms and clinical implications.Arch Microbiol2026https://conductscience.org/library/papers/42126606PubMed
42079437Decoy Nanoparticles and Protein Corona Modulation: A Novel Frontier in Sepsis Treatment.Int J Nanomedicine2026https://conductscience.org/library/papers/42079437PubMed
41278154Research progress concerning the involvement of the intestinal microbiota in the occurrence and development of inflammatory bowel disease.World J Gastroenterol2025https://conductscience.org/library/papers/41278154PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40686644

GET https://conductscience.org/api/papers/v1/40686644/references?page=2